Search by Drug Name or NDC
NDC 16571-0827-09 CAPTOPRIL AND HYDROCHLOROTHIAZIDE 25; 15 mg/1; mg/1 Details
CAPTOPRIL AND HYDROCHLOROTHIAZIDE 25; 15 mg/1; mg/1
CAPTOPRIL AND HYDROCHLOROTHIAZIDE is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Rising Pharma Holdings, Inc.. The primary component is CAPTOPRIL; HYDROCHLOROTHIAZIDE.
MedlinePlus Drug Summary
The combination of captopril and hydrochlorothiazide is used to treat high blood pressure. Captopril is in a class of medications called angiotensin-converting enzyme (ACE) inhibitors. It works by decreasing certain chemicals that tighten the blood vessels, so blood flows more smoothly. Hydrochlorothiazide is in a class of medications called diuretics ('water pills'). It works by causing the kidneys to get rid of unneeded water and salt from the body into the urine. High blood pressure is a common condition, and when not treated it can cause damage to the brain, heart, blood vessels, kidneys, and other parts of the body. Damage to these organs may cause heart disease, a heart attack, heart failure, stroke, kidney failure, loss of vision, and other problems. In addition to taking medication, making lifestyle changes will also help to control your blood pressure. These changes include eating a diet that is low in fat and salt, maintaining a healthy weight, exercising at least 30 minutes most days, not smoking, and using alcohol in moderation.
Related Packages: 16571-0827-09Last Updated: 03/24/2024
MedLinePlus Full Drug Details: Captopril and Hydrochlorothiazide
Product Information
| NDC | 16571-0827 |
|---|---|
| Product ID | 16571-827_0ea90fd4-0da6-4ad2-ab83-6cfbe0ae515e |
| Associated GPIs | |
| GCN Sequence Number | 000374 |
| GCN Sequence Number Description | captopril/hydrochlorothiazide TABLET 25 MG-15MG ORAL |
| HIC3 | A4J |
| HIC3 Description | ACE INHIBITOR-THIAZIDE OR THIAZIDE-LIKE DIURETIC |
| GCN | 54940 |
| HICL Sequence Number | 000127 |
| HICL Sequence Number Description | CAPTOPRIL/HYDROCHLOROTHIAZIDE |
| Brand/Generic | Generic |
| Proprietary Name | CAPTOPRIL AND HYDROCHLOROTHIAZIDE |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | CAPTOPRIL AND HYDROCHLOROTHIAZIDE |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET |
| Route | ORAL |
| Active Ingredient Strength | 25; 15 |
| Active Ingredient Units | mg/1; mg/1 |
| Substance Name | CAPTOPRIL; HYDROCHLOROTHIAZIDE |
| Labeler Name | Rising Pharma Holdings, Inc. |
| Pharmaceutical Class | Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA074896 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 16571-0827-09 (16571082709)
| NDC Package Code | 16571-827-09 |
|---|---|
| Billing NDC | 16571082709 |
| Package | 90 TABLET in 1 BOTTLE (16571-827-09) |
| Marketing Start Date | 2023-02-14 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |